Skip to main content
. 2022 Jul 28;14(15):3663. doi: 10.3390/cancers14153663
AA AA Amyloidosis
AML Acute myeloid leukemia
ANCA Antineutrophil cytoplasmic antibodies
ASCT Autologous stem cell transplantation
CAR-T Chimeric antigen receptor T-cell therapy
CCL5 C-C motif chemokine ligand 5
CH Clonal hematopoiesis
CHF Congestive heart failure
CHIP Clonal hematopoiesis of indeterminate potential
CVD Cardiovascular diseases
CXCL C-X-C motif ligand
DNMT3A DNA methyltransferase 3 alpha
HSC Hematopoietic stem cells
HIV Human immunodeficiency virus
IMiD Immunomodulatory drug
MDS Myelodysplastic syndrome
MDS-PA MDS phenotypic alterations
MGUS Monoclonal gammopathy of unknown significance
MM Multiple myeloma
NGS Next Generation Sequencing
NHL Non-Hodgkin lymphoma
OS Overall survival
PFS Progression-free survival
PV Polycythemia vera
RA Rheumatoid arthritis
TET2 Tet methylcytosine dioxygenase 2
tMN Therapy-related myeloid neoplasms
TNF Tumor necrosis factor
UC Ulcerative colitis
VAF Variant allele frequency
WM Waldenström’s macroglobulinemia
WES Whole exome sequencing